Accurate and timely cerebrospinal fluid (CSF) cell counts are critical in the diagnosis of meningitis, malignancy, demyelinating disease and hemorrhage. Due to historical limitations with the linearity of automated analyzers, CSF cell counts have traditionally been performed manually with a hemocytometer and the aid of a brightfield optical microscope. Manual cell counting is time-consuming, subjective due to reliance on human interpretation and requires a high degree of skill. This poses significant challenges for clinical laboratories of all sizes facing unprecedented staffing shortages. It also poses challenges for physicians who rely on timely results to provide appropriate patient management.
In this webinar, the featured speakers will discuss the importance of accurate and timely CSF cell counts and the positive impact of implementing a US Food and Drug Administration (FDA)-cleared advancement in CSF cell counting technology through case studies from three hospitals in the US.
Register for this webinar to develop a comprehensive understanding of the criticality of accurate and timely CSF cell counts and an automated solution designed to:
(1) free up tech time & improve result turnaround times,
(2) increase lab staff satisfaction & decrease stress levels, and
(3) eliminate errors associated with manual CSF cell counts & improve result accuracy.
Please fill out the form to view this content.